Introduction Emerging evidence points to an association between severe clinical
presentation of COVID-19 and increased risk of thromboembolism. One-third of patients …

Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV‑2), is now a global pandemic. This virus primarily …

Background Infection by the 2019 novel coronavirus (COVID-19) has been reportedly
associated with a high risk of thrombotic complications. So far information is scarce and …

COVID-19 is associated with a high incidence of thrombotic complications, which can be
explained by the complex and unique interplay between coronaviruses and endothelial …

Abstract Purpose of Review Novel coronavirus disease 2019 (COVID-19) has been
associated with an increased risk of arterial and venous thromboembolic (VTE) diseases …

Abstract COVID-19-associated coagulopathy (CAC) is a feature of COVID-19 that can lead
to various thrombotic complications and death. In this review, we briefly highlight possible …

A prothrombotic state is reported with severe COVID-19 infection, which can manifest in
venous and arterial thrombotic events. Coagulopathy is reflective of more severe disease …

Coronavirus-2019 (COVID-19) predisposes patients to arterial and venous thrombosis
commonly complicating the clinical course of hospitalized patients and attributed to the …

Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has led to a worldwide
pandemic, and patients with the infection are referred to as having COVID‐19. Although …

Background Coagulation abnormalities in COVID-19 patients accompanied with poor
prognosis. This study aimed to determine the prevalence and risk factors of thrombotic …